New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
04:55 EDTSNE, SNE, SNE, SNE, SNE, SCMP, SCMP, SCMP, SCMP, SCMP, PRGO, PRGO, PRGO, PRGO, PRGO, OMER, OMER, OMER, OMER, OMER, NBY, NBY, NBY, NBY, NBY, LMNS, LMNS, LMNS, LMNS, LMNS, HALO, HALO, HALO, HALO, HALO, CAJ, CAJ, CAJ, CAJ, CAJ, AKRX, AKRX, AKRX, AKRX, AKRX, AGN, AGN, AGN, AGN, AGN, ACL, ACL, ACL, ACL, ACL, ABT, ABT, ABT, ABT, ABTAmerican Society of Cataract and Refractive Surgery to hold a symposium
2014 ASCRS-SOA Symposium & Congress is being held in Boston, MA on April 25-29.
News For ABT;ACL;AGN;AKRX;CAJ;HALO;LMNS;NBY;OMER;PRGO;SCMP;SNE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
November 12, 2014
16:53 EDTAGNAllergan receives FDA approval for new styles of NATRELLE 410
Subscribe for More Information
10:09 EDTAGNActavis in talks to buy Allergan for over $200 per share, Bloomberg says
Subscribe for More Information
10:01 EDTAGNActavis in talks to buy Allergan for $60B, more than $200/share Bloomberg says
Actavis (ACT) is said to seek to pay about $200 per share, but Allergan (AGN) seeks about $210 per share, according to Bloomberg.
08:02 EDTAKRX, LMNSCredit Suisse to hold a conference
Subscribe for More Information
07:22 EDTCAJAssociation of Molecular Pathology is holding annual meeting
2014 Annual Meeting of AMP is being held in National Harbor, Maryland on November 12-15.
07:09 EDTNBYNovaBay reports Q3 EPS (8c), consensus (9c)
Reports Q3 revenue $90,000, one estimate $200,000.
07:01 EDTAGNAllergan announces approval of amendments to company bylaws
Subscribe for More Information
06:22 EDTAGNZoetis price target raised to $49 from $44 at Citigroup
Citigroup raised its price target for Zoetis (ZTS) shares to $49 after activist Pershing Square confirmed the accumulation of a 10% stake in the company. Citi thinks Pershing is interested in advocating for a sale of Zoetis, potentially to Valeant (VRX) if its bid for Allergan (AGN) fails. Citi believes others, including Bayer (BAYRY), could be interested in acquiring Zoetis. It keeps a Buy rating on the stock.
November 11, 2014
16:20 EDTLMNSLumenis sees FY14 EPS 51c-55c, consensus 53c
Subscribe for More Information
16:18 EDTLMNSLumenis reports Q3 EPS 17c, consensus 14c
Reports Q3 revenue $74.2M, consensus $71.94M..
15:46 EDTAGNPershing Square, Sachem Head build 10% stake in Zoetis, WSJ reports
Subscribe for More Information
09:18 EDTHALOHalozyme price target lowered to $10 from $12 at JMP Securities
JMP Securities cut its price target on Halozyme after the company said it intends to explore partnerships and/or strategic alternatives for the Hylenex program in diabetes. The firm removed the diabetes program from its valuation due to uncertainty. It reiterates an Outperform rating on the shares.
08:32 EDTAGNValeant likely to raise offer for Allergan again, says Bernstein
Subscribe for More Information
November 10, 2014
18:32 EDTHALOOn The Fly: After Hours Movers
Subscribe for More Information
17:26 EDTHALOHalozyme completes workforce reduction
The company noted, "We completed a corporate reorganization to align with strategic priorities. This reorganization resulted in a workforce reduction of 22 employees. We will incur a one-time charge in Q414 that will be largely offset by reduced compensation expenses during the quarter."
16:19 EDTHALOHalozyme reports Q3 EPS (16c), consensus (14c)
Subscribe for More Information
16:12 EDTOMEROmeros reports Q3 EPS (54c), consensus (59c)
Subscribe for More Information
15:53 EDTPRGOCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
15:26 EDTHALONotable companies reporting after market close
Subscribe for More Information
07:19 EDTPRGOCredit Suisse to hold a conference
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use